West Pharmaceutical
About: West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Employees: 10,600
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
33% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 4 (+1) [Q3]
11% more repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 257
1.65% less ownership
Funds ownership: 94.88% [Q2] → 93.23% (-1.65%) [Q3]
9% less funds holding
Funds holding: 768 [Q2] → 701 (-67) [Q3]
11% less capital invested
Capital invested by funds: $22.7B [Q2] → $20.2B (-$2.48B) [Q3]
39% less call options, than puts
Call options by funds: $92.1M | Put options by funds: $152M
53% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 127
Research analyst outlook
We haven’t received any recent analyst ratings for WST.
Financial journalist opinion
Based on 13 articles about WST published over the past 30 days
